Evidence map›Paper›PMID 40261655›Full record

ArticleJAMA network open2025

Breast Cancer Stage Among Ukrainian Refugees in Poland.

Jakub Skórniak, Lukasz Rabalski, Bartlomiej Szynglarewicz, Bartosz Dolega-Kozierowski, Piotr Kasprzak, Marcin Zietek, Adam Maciejczyk, Edyta Pawlak, Martyna Krejmer-Rabalska, Katarzyna Skuza and 1 more

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jakub SkórniakBreast Unit, Wroclaw Comprehensive Cancer Centre, Wroclaw, Poland.
Lukasz RabalskiBiological Threats Identification and Countermeasure Centre, Military Institute of Hygiene and Epidemiology, Pulawy, Poland.
Bartlomiej SzynglarewiczBreast Unit, Wroclaw Comprehensive Cancer Centre, Wroclaw, Poland.
Bartosz Dolega-KozierowskiBreast Unit, Wroclaw Comprehensive Cancer Centre, Wroclaw, Poland.
Piotr KasprzakBreast Unit, Wroclaw Comprehensive Cancer Centre, Wroclaw, Poland.
Marcin ZietekBreast Unit, Wroclaw Comprehensive Cancer Centre, Wroclaw, Poland.
Adam MaciejczykBreast Unit, Wroclaw Comprehensive Cancer Centre, Wroclaw, Poland.
Edyta PawlakLaboratory of Immunopathology, Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Martyna Krejmer-RabalskaDepartment of Recombinant Vaccines, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Gdansk, Poland.
Katarzyna SkuzaBiological Threats Identification and Countermeasure Centre, Military Institute of Hygiene and Epidemiology, Pulawy, Poland.
Rafal MatkowskiBreast Unit, Wroclaw Comprehensive Cancer Centre, Wroclaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Millions of Ukrainians displaced by war have sought refuge in Poland, posing challenges for cancer care. Determining whether these refugees present with more-advanced breast cancer is crucial for guiding resource allocation. Objective: To evaluate the associations between Ukrainian refugee status and clinical presentation of breast cancer compared with Ukrainian permanent residents in Poland and the general Polish population. Design, Setting, and Participants: This retrospective cohort study was conducted between February 2021 and February 2024 at a single tertiary oncology center (Lower Silesian Oncology, Pulmonology, and Hematology Centre, Wrocław, Poland) and included adult women with a diagnosis of stage 0 to IV breast cancer, regardless of treatment intent. Participants were categorized as Ukrainian permanent residents (UPRs), Ukrainian war refugees (UWRs), or general Polish population (GPP). Exposures: War refugee status (UWR) vs permanent residence (UPR) vs general Polish population (GPP) and a diagnosis of breast cancer. Main Outcomes and Measures: Primary outcomes were clinical stage (0-IV) at diagnosis, tumor grade (G1-G3), and age at presentation. Stage distributions and odds ratios (ORs) were evaluated using weighted logistic regression, adjusting for age and time period (before the war, first war year, and second war year). Results: Of 3259 patients, 44 were in the UWR group (mean [SD] age, 52.9 [13.5] years), 72 were in the UPR group (mean [SD] age, 49.9 [11.4] years), and 3143 were in the GPP group (mean [SD] age, 59.5 [12.6] years). Stage III to IV disease occurred in 19 patients (43.2%) in the UWR group vs 849 patients (27.0%) in the GPP group. Adjusted analysis showed that refugees had a 2.00-fold increased odds (95% CI, 1.06-3.76; P = .03) of stage III to IV disease and 2.42-fold increased odds (95% CI, 1.29-4.55; P = .006) of grade 3 tumors. Conclusions and Relevance: In this retrospective cohort study, war refugee status was associated with a higher prevalence of aggressive tumor grades and more-advanced stage disease at diagnosis. Although aggressive breast cancer subtypes are more common in younger women, the disproportionate burden of advanced disease in this cohort highlights the impact of health care access barriers and delayed presentation. These findings underscore the need for tailored strategies, such as accessible screening and early diagnostic interventions, to improve outcomes among Ukrainian refugees in Poland.

Indexed as

Breast NeoplasmsRefugeesAdultAgedFemaleHumansMiddle AgedNeoplasm StagingPolandRetrospective StudiesUkraine

Identifiers

PMID40261655
PMCPMC12015669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.